Last reviewed · How we verify

amoxicillin/clavulanate potassium 1gm

GlaxoSmithKline · FDA-approved active Small molecule

amoxicillin/clavulanate potassium 1gm is a Beta-lactam antibiotic with beta-lactamase inhibitor Small molecule drug developed by GlaxoSmithKline. It is currently FDA-approved for Bacterial infections caused by susceptible organisms including otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.

Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, while clavulanate potassium inhibits beta-lactamase enzymes that would otherwise inactivate amoxicillin.

Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, while clavulanate potassium inhibits beta-lactamase enzymes that would otherwise inactivate amoxicillin. Used for Bacterial infections caused by susceptible organisms including otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.

At a glance

Generic nameamoxicillin/clavulanate potassium 1gm
SponsorGlaxoSmithKline
Drug classBeta-lactam antibiotic with beta-lactamase inhibitor
TargetPenicillin-binding proteins (PBPs); bacterial beta-lactamase
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

Amoxicillin is a beta-lactam antibiotic that disrupts peptidoglycan cross-linking in bacterial cell walls, leading to cell lysis and death. Clavulanate potassium is a beta-lactamase inhibitor that protects amoxicillin from degradation by bacterial beta-lactamase enzymes, thereby extending amoxicillin's spectrum of activity to include beta-lactamase-producing organisms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about amoxicillin/clavulanate potassium 1gm

What is amoxicillin/clavulanate potassium 1gm?

amoxicillin/clavulanate potassium 1gm is a Beta-lactam antibiotic with beta-lactamase inhibitor drug developed by GlaxoSmithKline, indicated for Bacterial infections caused by susceptible organisms including otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.

How does amoxicillin/clavulanate potassium 1gm work?

Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, while clavulanate potassium inhibits beta-lactamase enzymes that would otherwise inactivate amoxicillin.

What is amoxicillin/clavulanate potassium 1gm used for?

amoxicillin/clavulanate potassium 1gm is indicated for Bacterial infections caused by susceptible organisms including otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.

Who makes amoxicillin/clavulanate potassium 1gm?

amoxicillin/clavulanate potassium 1gm is developed and marketed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).

What drug class is amoxicillin/clavulanate potassium 1gm in?

amoxicillin/clavulanate potassium 1gm belongs to the Beta-lactam antibiotic with beta-lactamase inhibitor class. See all Beta-lactam antibiotic with beta-lactamase inhibitor drugs at /class/beta-lactam-antibiotic-with-beta-lactamase-inhibitor.

What development phase is amoxicillin/clavulanate potassium 1gm in?

amoxicillin/clavulanate potassium 1gm is FDA-approved (marketed).

What are the side effects of amoxicillin/clavulanate potassium 1gm?

Common side effects of amoxicillin/clavulanate potassium 1gm include Diarrhea, Nausea, Vomiting, Rash, Abdominal pain, Allergic reactions (including anaphylaxis).

What does amoxicillin/clavulanate potassium 1gm target?

amoxicillin/clavulanate potassium 1gm targets Penicillin-binding proteins (PBPs); bacterial beta-lactamase and is a Beta-lactam antibiotic with beta-lactamase inhibitor.

Related